As of March 21, the CDC has identified 68 patients in 16 states affected by eye drops potentially contaminated with Pseudomonas aeruginosa. Three people have died, eight have lost vision and four had an eyeball surgically removed, according to a news release from the agency.
This strain of a highly drug-resistant bacteria has not been identified in the U.S. before. The CDC found the bacteria in opened bottles of EzriCare and is testing unopened bottles. So far, unopened bottles have shown no signs of contamination, according to the report, but additional bottles are being tested.
The FDA recalled three products manufactured by Global Pharma Healthcare Private Limited in connection to this bacteria outbreak.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.